David Mattson

  • 2376 Citations
  • 25 h-Index
1980 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where David Mattson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Multiple Sclerosis Medicine & Life Sciences
Oligoclonal Bands Medicine & Life Sciences
Subacute Sclerosing Panencephalitis Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Placebos Medicine & Life Sciences
Progressive Multifocal Leukoencephalopathy Medicine & Life Sciences
Chronic Progressive Multiple Sclerosis Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1980 2018

  • 2376 Citations
  • 25 h-Index
  • 52 Article
  • 1 Chapter
  • 1 Letter
36 Citations (Scopus)
Chronic Progressive Multiple Sclerosis
Disease Progression
Placebos
Odds Ratio
Natalizumab
3 Citations (Scopus)

Systemic acrolein elevations in mice with experimental autoimmune encephalomyelitis and patients with multiple sclerosis

Tully, M., Tang, J., Zheng, L., Acosta, G., Tian, R., Hayward, L., Race, N., Mattson, D. & Shi, R., Jun 15 2018, In : Frontiers in Neurology. 9, JUN, 420.

Research output: Contribution to journalArticle

Acrolein
Autoimmune Experimental Encephalomyelitis
Multiple Sclerosis
hydroxypropyl methacrylate
Urine
13 Citations (Scopus)

Safety/tolerability of the anti-semaphorin 4D antibody VX15/2503 in a randomized phase 1 trial

LaGanke, C., Samkoff, L., Edwards, K., Henson, L. J., Repovic, P., Lynch, S., Stone, L., Mattson, D., Galluzzi, A., Fisher, T. L., Reilly, C., Winter, L. A., Leonard, J. E. & Zauderer, M., 2017, In : Neurology: Neuroimmunology and NeuroInflammation. 4, 4

Research output: Contribution to journalArticle

Safety
Antibody Formation
Antibodies
Pharmacokinetics
Placebos
2 Citations (Scopus)

Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis - Performance improvement CME

Miller, A. E., Cohen, B. A., Krieger, S. C., Markowitz, C. E., Mattson, D. & Tselentis, H. N., Jan 2014, In : Multiple Sclerosis. 20, 1, p. 18-23 6 p.

Research output: Contribution to journalArticle

Disease Management
Multiple Sclerosis
Continuing Medical Education
Fatigue
Documentation
9 Citations (Scopus)

A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing

Mazda, M. E., Brosch, J. R., Wiens, A. L., Bonnin, J., Kamer, A. P., Mattson, D. & Snook, R. J., May 2013, In : International Journal of Neuroscience. 123, 5, p. 353-357 5 p.

Research output: Contribution to journalArticle

JC Virus
Progressive Multifocal Leukoencephalopathy
Routine Diagnostic Tests
Multiple Sclerosis
DNA-Directed DNA Polymerase